Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SARS-CoV-2 (COVID-19) S1 (D614G) Recombinant Protein | Login | SARS-CoV-2 (COVID-19) S1 (D614G) Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| SARS-CoV-2 (COVID-19) S-trimer (D614G) Recombinant Protein | Login | SARS-CoV-2 (COVID-19) S-trimer (D614G) Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein | Login | SARS-CoV-2 (COVID-19) NSP1 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| SARS-CoV-2 (COVID-19) Envelope Recombinant Protein | Login | SARS-CoV-2 (COVID-19) Envelope Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| SARS-CoV-2 (COVID-19) NP CTD domain Recombinant Protein | Login | SARS-CoV-2 (COVID-19) NP CTD domain Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| PUMA Fragment Recombinant Protein | Login | PUMA Fragment Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| MyD88 Fragment Recombinant Protein | Login | MyD88 Fragment Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| CD4 Fragment Recombinant Protein | Login | CD4 Fragment Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| IRAK Recombinant Protein | Login | IRAK Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| RCAN2 Isoform 2 Recombinant Protein | Login | RCAN2 Isoform 2 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| MTCH2 Recombinant Protein | Login | MTCH2 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| DR6 Cytoplasmic Domain Recombinant Protein | Login | DR6 Cytoplasmic Domain Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| DR6 Extracellular Domain Recombinant Protein | Login | DR6 Extracellular Domain Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [6G9] | Login | Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [6G9] | ||||||||||||||||
|
||||||||||||||||||
| Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [4A6] | Login | Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antibody [4A6] | ||||||||||||||||
|
||||||||||||||||||
| Recombinant SARS-CoV-2 (COVID-19) S Antibody [5E8] | Login | Recombinant SARS-CoV-2 (COVID-19) S Antibody [5E8] | ||||||||||||||||
|
||||||||||||||||||
| Recombinant SARS-CoV-2 (COVID-19) S Antibody [2B7] | Login | Recombinant SARS-CoV-2 (COVID-19) S Antibody [2B7] | ||||||||||||||||
|
||||||||||||||||||
| Recombinant SARS-CoV-2 (COVID-19) S1 Antibody [5D9] | Login | Recombinant SARS-CoV-2 (COVID-19) S1 Antibody [5D9] | ||||||||||||||||
|
||||||||||||||||||
| SARS-CoV-2 Spike P681H Antibody (Alpha, Mu Variant) | Login | SARS-CoV-2 Spike P681H Antibody (Alpha, Mu Variant) | ||||||||||||||||
|
||||||||||||||||||
| SARS-CoV-2 Spike P681H Antibody (Alpha, Mu Variant) | Login | SARS-CoV-2 Spike P681H Antibody (Alpha, Mu Variant) | ||||||||||||||||
|
||||||||||||||||||
| Serpin B1 Recombinant Protein | Login | Serpin B1 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| BMP Receptor IA Recombinant Protein | Login | BMP Receptor IA Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Semaphorin 4D Recombinant Protein | Login | Semaphorin 4D Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Plasma glutamate carboxypeptidase Recombinant Protein | Login | Plasma glutamate carboxypeptidase Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||
| Siglec-3 Recombinant Protein | Login | Siglec-3 Recombinant Protein | ||||||||||||||||
|
||||||||||||||||||


